PetVivo Holdings, Inc. (PETV)
OTCMKTS · Delayed Price · Currency is USD
0.8070
+0.0070 (0.88%)
Aug 1, 2025, 3:38 PM EDT
PetVivo Holdings Company Description
PetVivo Holdings, Inc., is an emerging biomedical device company focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals.
It is also engaging in the veterinary market to treat and/or manage afflictions of companion animals such as cats, dogs and horses.
Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.
The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications.
PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
PetVivo Holdings, Inc.
| Country | United States |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 24 |
| CEO | John Lai |
Contact Details
Address: 5151 Edina Industrial Boulevard Edina, Nevada 55439 United States | |
| Phone | 952 405 6216 |
| Website | petvivo.com |
Stock Details
| Ticker Symbol | PETV |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | US7168174081 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| John Lai | Chief Executive Officer, President and Director |
| Garry N. Lowenthal | Chief Financial Officer |
| Michael Eldred BA, MBA | Commercialization and Operations Advisor and Executive Director |
| John F. Dolan | General Counsel, Chief Business Development Officer and Secretary |
| April Boyce | Vice President of Sales and Marketing |